ZA83673B - Nasal pharmaceutical compositions - Google Patents

Nasal pharmaceutical compositions

Info

Publication number
ZA83673B
ZA83673B ZA83673A ZA83673A ZA83673B ZA 83673 B ZA83673 B ZA 83673B ZA 83673 A ZA83673 A ZA 83673A ZA 83673 A ZA83673 A ZA 83673A ZA 83673 B ZA83673 B ZA 83673B
Authority
ZA
South Africa
Prior art keywords
pharmaceutical compositions
nasal pharmaceutical
nasal
compositions
pharmaceutical
Prior art date
Application number
ZA83673A
Inventor
Jean-Rene Kiechel
Francoise Acezat-Mispelter
Daniele Plas
Original Assignee
Sandoz Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ltd filed Critical Sandoz Ltd
Publication of ZA83673B publication Critical patent/ZA83673B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
ZA83673A 1982-02-01 1983-02-01 Nasal pharmaceutical compositions ZA83673B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8202781 1982-02-01

Publications (1)

Publication Number Publication Date
ZA83673B true ZA83673B (en) 1984-09-26

Family

ID=10528017

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA83673A ZA83673B (en) 1982-02-01 1983-02-01 Nasal pharmaceutical compositions

Country Status (27)

Country Link
JP (1) JPS58134017A (en)
AT (1) AT385656B (en)
AU (1) AU565613B2 (en)
BE (1) BE895750A (en)
CA (1) CA1197783A (en)
CH (1) CH653555A5 (en)
DE (1) DE3302949A1 (en)
DK (1) DK164771C (en)
ES (1) ES8502865A1 (en)
FI (1) FI81258C (en)
FR (1) FR2539994B1 (en)
GR (1) GR81320B (en)
HK (1) HK59989A (en)
HU (1) HU191512B (en)
IE (1) IE54532B1 (en)
IL (1) IL67822A (en)
IT (1) IT1197558B (en)
KE (1) KE3888A (en)
LU (1) LU84613A1 (en)
MY (1) MY8700766A (en)
NL (1) NL192325C (en)
NZ (1) NZ203117A (en)
PH (1) PH22198A (en)
PT (1) PT76166B (en)
SE (1) SE454402B (en)
SG (1) SG34389G (en)
ZA (1) ZA83673B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0715285D0 (en) * 2007-08-06 2007-09-12 Britannia Pharmaceuticals Ltd Improvements in or relating to powdered medicaments for nasal delivery
GB0910375D0 (en) * 2009-06-16 2009-07-29 Biocopea Ltd Drug composition and its use in therapy
BR112020013744A8 (en) * 2018-01-05 2022-10-18 Impel Neuropharma Inc DIHYDROERGOTAMINE INTRANASAL DISPENSATION BY PRECISION OLFATIVE DEVICE

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3091569A (en) * 1960-08-26 1963-05-28 Mead Johnson & Co Mucolytic-nu-acylated sulfhydryl compositions and process for treating animal mucus
GB1202885A (en) * 1966-12-22 1970-08-19 Sandoz Ltd Pharmaceutical compositions comprising alkaloids
DE2750090A1 (en) * 1976-11-19 1978-06-01 Sandoz Ag NEW FORMS OF ADMINISTRATION FOR ORGANIC COMPOUNDS
FR2387035A1 (en) * 1977-04-12 1978-11-10 Cassenne Lab Sa NEW MEDICINAL PRODUCT INTENDED IN PARTICULAR FOR THE TREATMENT OF FUNCTIONAL CEREBRAL DISORDERS
DE2831728C2 (en) * 1978-07-19 1982-12-23 Krewel-Werke Gmbh, 5208 Eitorf Medicines used to treat headaches

Also Published As

Publication number Publication date
BE895750A (en) 1983-08-01
DK164771B (en) 1992-08-17
HU191512B (en) 1987-02-27
PT76166A (en) 1983-02-01
DK38183D0 (en) 1983-01-31
NZ203117A (en) 1986-12-05
PT76166B (en) 1986-02-04
IL67822A (en) 1988-02-29
LU84613A1 (en) 1983-09-08
JPS58134017A (en) 1983-08-10
ATA30383A (en) 1987-10-15
IE54532B1 (en) 1989-11-08
FR2539994B1 (en) 1986-10-10
FI830245A0 (en) 1983-01-25
AU1085083A (en) 1983-08-11
SG34389G (en) 1989-09-22
DE3302949C2 (en) 1992-05-21
FI830245L (en) 1983-08-02
SE8300495L (en) 1983-08-02
NL8300325A (en) 1983-09-01
AU565613B2 (en) 1987-09-24
DK164771C (en) 1992-12-28
ES519450A0 (en) 1985-02-01
AT385656B (en) 1988-05-10
IT8347646A0 (en) 1983-02-01
SE454402B (en) 1988-05-02
PH22198A (en) 1988-06-28
DE3302949A1 (en) 1983-08-11
KE3888A (en) 1989-09-01
CA1197783A (en) 1985-12-10
DK38183A (en) 1983-08-02
IE830187L (en) 1983-08-01
IT1197558B (en) 1988-12-06
IL67822A0 (en) 1983-06-15
HK59989A (en) 1989-08-04
FI81258B (en) 1990-06-29
SE8300495D0 (en) 1983-01-31
MY8700766A (en) 1987-12-31
FI81258C (en) 1990-10-10
GR81320B (en) 1984-12-11
FR2539994A1 (en) 1984-08-03
CH653555A5 (en) 1986-01-15
JPH0253406B2 (en) 1990-11-16
NL192325B (en) 1997-02-03
NL192325C (en) 1997-06-04
ES8502865A1 (en) 1985-02-01

Similar Documents

Publication Publication Date Title
GB8326565D0 (en) Pharmaceutical compositions
HK16090A (en) Pharmaceutical compositions
IL69892A0 (en) Pharmaceutical compositions comprising calcitonin
ZA834074B (en) Pharmaceutical composition
ZA833781B (en) Pharmaceutical compositions
EP0093551A3 (en) Pharmaceutical composition
GB2118176B (en) Pharmaceutical compositions
GB2117766B (en) Pharmaceutical compositions
PT77323B (en) Pharmaceutical compositions
GB8429749D0 (en) Pharmaceutical compositions
GB8313814D0 (en) Pharmaceutical compositions
GB8329700D0 (en) Anti-haemophilic pharmaceutical composition
DE3377696D1 (en) Pharmaceutical compositions
GB8302374D0 (en) Nasal pharmaceutical compositions
GB8328896D0 (en) Pharmaceutical composition
US4594359B1 (en) Pharmaceutical compositions
IL67822A0 (en) Nasal pharmaceutical compositions
GB8305028D0 (en) Pharmaceutical compositions
GB8314736D0 (en) Pharmaceutical compositions
GB8330810D0 (en) Pharmaceutical compositions
GB8332653D0 (en) Pharmaceutical composition
GB8331068D0 (en) Pharmaceutical compositions
GB8329391D0 (en) Pharmaceutical compositions
GB8314540D0 (en) Pharmaceutical composition
DE3372706D1 (en) Pharmaceutical compositions